Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18400183 | 0.79 | TYR (0.41) | KMT2ACYP2D6LMNAHIF1AKDM4E | |
| SCHEMBL577805 | 0.78 | ALDH1A1 (0.46) | KMT2AL3MBTL1TAAR1CYP2D6ADRA2A | |
| SCHEMBL775627 | 0.78 | KMT2A (0.45) | KMT2AL3MBTL1TAAR1CYP2D6ADRA2A | |
| SCHEMBL24815603 | 0.77 | CHRNA7 (0.41) | KMT2ALMNAALDH1A1TSHR | |
| SCHEMBL20809867 | 0.76 | KMT2A (0.44) | KMT2AL3MBTL1TAAR1CYP2D6ADRA2A | |
| SCHEMBL14535430 | 0.76 | KMT2A (0.44) | KMT2AL3MBTL1TAAR1CYP2D6ADRA2A | |
| SCHEMBL1145689 | 0.76 | KMT2A (0.44) | KMT2AL3MBTL1TAAR1CYP2D6ADRA2A | |
| SCHEMBL12125569 | 0.75 | RIPK1 (0.42) | KMT2AL3MBTL1TAAR1CYP2D6ADRA2A | |
| SCHEMBL776753 | 0.75 | TAAR1 (0.40) | TAAR1CYP2D6ADRA2AADRA2CLMNA | |
| SCHEMBL24816603 | 0.75 | ESR1 (0.54) | KMT2ATAAR1CYP2D6LMNAHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116272906-A | Super cross-linked polymer adsorption material containing paired mercapto and preparation method thereof | 哈尔滨工程大学 | 2023-06-23 | — | — | CN | claimed |
| CN-113265155-A | Asphalt tackifier and preparation method thereof | 山东鑫中和新材料科技有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-113122058-A | Preparation method of ink and quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PROLX PHARMACEUTICALS CORPORATION (CA) | 2003-09-18 | — | — | US | claimed |
| CN-120001297-A | Capsule | 宝洁公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-113660926-B | capsule | 宝洁公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-114007734-B | Method for preparing capsules | 宝洁公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-116272906-B | Super cross-linked polymer adsorption material containing paired mercapto and preparation method thereof | 哈尔滨工程大学 | 2024-12-20 | — | — | CN | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-114478326-B | Synthesis method of saflufenacil key intermediate | 安徽宁亿泰科技有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20230265094-A1 | RIPK1 INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2023-08-24 | — | — | US | disclosed |
| CN-116272906-A | Super cross-linked polymer adsorption material containing paired mercapto and preparation method thereof | 哈尔滨工程大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-1749238-A | Saturated and unsaturated N-alkylamides with taste and flavour enhancing effect in flavour compositions | INT FLAVORS & FRAGRANCES INC (US) | 2006-03-22 | — | — | CN | disclosed |
| WO-2006023658-A2 | METHOD OF PRE-SELECTING PATIENTS FOR ANTI-VEGF, ANTI-HIF-1 OR ANTI-THIOREDOXIN THERAPY | PROLX PHARMACEUTICALS CORP. (US) | 2006-03-02 | — | — | WO | disclosed |
| WO-2005007108-A2 | ASYMMETRIC DISULFIDES AND METHODS OF USING SAME | PROLX PHARMACEUTICALS, INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| US-20040116496-A1 | Asymmetric Disulfides and methods of using same | PROLX PHARMACEUTICALS CORP. | 2004-06-17 | — | — | US | disclosed |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PROLX PHARMACEUTICALS CORPORATION (CA) | 2003-09-18 | — | — | US | disclosed |
| US-6552060-B1 | Inhibits abnormal cellular proliferation and restores or prevents inhibition of cellular apoptosis | PROLX PHARMACEUTICALS, INC. | 2003-04-22 | — | — | US | disclosed |
| EP-0555058-B1 | (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition | TOYO INK MFG CO (JP) | 1997-05-07 | — | — | EP | disclosed |
| EP-0555058-A1 | (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition | TOYO INK MANUFACTURING CO., LTD. (JP) | 1993-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265094-A1 | RIPK1 INHIBITORS AND METHODS OF USE | RIPK1, RIPK2, RIPK3 | KMT2A 3938/4885L3MBTL1 2158/4885TAAR1 4749/4885 |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PRDX3, PDIA5, PRDX5 | KMT2A 4152/4885L3MBTL1 1185/4885TAAR1 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.